Detalhe da pesquisa
1.
SARS-CoV-2 Clinical Outcomes in Patients with Cancer in a Large Integrated Health Care System in Northern California.
Oncologist
; 26(3): e500-e504, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33210439
2.
A phase II trial of AS1411 (a novel nucleolin-targeted DNA aptamer) in metastatic renal cell carcinoma.
Invest New Drugs
; 32(1): 178-87, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24242861
3.
Choriocarcinoma Syndrome: A Rare Complication's Impact on Metastatic Germ Cell Tumor Outcomes.
Cureus
; 16(4): e58388, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38756265
4.
Quality of life for men with metastatic castrate-resistant prostate cancer participating in an aerobic and resistance exercise pilot intervention.
Urol Oncol
; 41(3): 146.e1-146.e11, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36528473
5.
Orteronel for Metastatic Hormone-Sensitive Prostate Cancer: A Multicenter, Randomized, Open-Label Phase III Trial (SWOG-1216).
J Clin Oncol
; 40(28): 3301-3309, 2022 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35446628
6.
A phase 1 study of everolimus and sorafenib for metastatic clear cell renal cell carcinoma.
Cancer
; 117(18): 4194-200, 2011 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21387258
7.
Ixabepilone, mitoxantrone, and prednisone for metastatic castration-resistant prostate cancer after docetaxel-based therapy: a phase 2 study of the Department Of Defense Prostate Cancer Clinical Trials Consortium.
Cancer
; 117(11): 2419-25, 2011 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24048789
8.
Implementation of a Multidisciplinary Expert Testicular Cancer Tumor Board Across a Large Integrated Healthcare Delivery System Via Early Case Ascertainment.
JCO Clin Cancer Inform
; 5: 187-193, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33571000
9.
Baseline Circulating Tumor Cell Count as a Prognostic Marker of PSA Response and Disease Progression in Metastatic Castrate-Sensitive Prostate Cancer (SWOG S1216).
Clin Cancer Res
; 27(7): 1967-1973, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33500355
10.
Immunotherapeutics in development for prostate cancer.
Oncologist
; 14(4): 391-8, 2009 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-19342474
11.
Preexisting Levels of CD4 T Cells Expressing PD-1 Are Related to Overall Survival in Prostate Cancer Patients Treated with Ipilimumab.
Cancer Immunol Res
; 3(9): 1008-16, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25968455
12.
Effects of cabozantinib on pain and narcotic use in patients with castration-resistant prostate cancer: results from a phase 2 nonrandomized expansion cohort.
Eur Urol
; 67(2): 310-8, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24631409
13.
Sequential use of the androgen synthesis inhibitors ketoconazole and abiraterone acetate in castration-resistant prostate cancer and the predictive value of circulating androgens.
Clin Cancer Res
; 20(24): 6269-76, 2014 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25336698
14.
Cabozantinib in chemotherapy-pretreated metastatic castration-resistant prostate cancer: results of a phase II nonrandomized expansion study.
J Clin Oncol
; 32(30): 3391-9, 2014 Oct 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-25225437
15.
Five-year survival in patients with cytokine-refractory metastatic renal cell carcinoma treated with axitinib.
Clin Genitourin Cancer
; 11(2): 107-14, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23391371
16.
Cabozantinib in patients with advanced prostate cancer: results of a phase II randomized discontinuation trial.
J Clin Oncol
; 31(4): 412-9, 2013 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23169517
17.
Metabolic imaging of patients with prostate cancer using hyperpolarized [1-¹³C]pyruvate.
Sci Transl Med
; 5(198): 198ra108, 2013 Aug 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-23946197
18.
Platinum-based chemotherapy for variant castrate-resistant prostate cancer.
Clin Cancer Res
; 19(13): 3621-30, 2013 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23649003
19.
Phase II and biomarker study of the dual MET/VEGFR2 inhibitor foretinib in patients with papillary renal cell carcinoma.
J Clin Oncol
; 31(2): 181-6, 2013 Jan 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-23213094
20.
Effect of the somatostatin analog octreotide acetate on circulating insulin-like growth factor-1 and related peptides in patients with non-metastatic castration-resistant prostate cancer: results of a phase II study.
Urol Oncol
; 30(4): 408-14, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-20884247